NCT05218278 NFL Dynamics as a Predictor Factor in Patients With Out of Hospital Cardiac Arrest
| NCT ID | NCT05218278 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Medical Centre Maribor |
| Condition | Out-Of-Hospital Cardiac Arrest |
| Study Type | OBSERVATIONAL |
| Enrollment | 60 participants |
| Start Date | 2022-01-01 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 60 participants in total. It began in 2022-01-01 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To investigate the pharmacodynamics of light chain of NFL in patients with out-of hospital cardiac arrest after successful resuscitation and determine the difference in the serum levels of NFL in patients with favorable neurological outcome compared to those with non-favorable neurological outcome.
Eligibility Criteria
Inclusion Criteria: * out-of-hospital cardiac arrest successfully resuscitated and admitted to the ICU Exclusion Criteria: * trauma, drowning, electrocution, less than 18 years of age,
Contact & Investigator
Matej Strnad, MD, PhD
PRINCIPAL INVESTIGATOR
University medical cenetr Maribor
Frequently Asked Questions
Who can join the NCT05218278 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Out-Of-Hospital Cardiac Arrest. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05218278 currently recruiting?
Yes, NCT05218278 is actively recruiting participants. Contact the research team at strnad.matej78@gmail.com for enrollment information.
Where is the NCT05218278 trial being conducted?
This trial is being conducted at Maribor, Slovenia.
Who is sponsoring the NCT05218278 clinical trial?
NCT05218278 is sponsored by University Medical Centre Maribor. The principal investigator is Matej Strnad, MD, PhD at University medical cenetr Maribor. The trial plans to enroll 60 participants.